These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

491 related items for PubMed ID: 22591041

  • 21. Does Cytokeratin7/20 immunoreactivity help to distinguish Barrett's esophagus from gastric intestinal metaplasia? Results of a prospective study of 75 patients.
    Schilling D, Spiethoff A, Rosenbaum A, Hartmann D, Eickhoff A, Jakobs R, Weickert U, Rebe M, Bohrer MH, Riemann JF.
    Pathol Res Pract; 2005; 200(11-12):801-5. PubMed ID: 15792123
    [Abstract] [Full Text] [Related]

  • 22. Origin of adenocarcinoma in Barrett's esophagus: p53 and Ki67 expression and histopathologic background.
    Szachnowicz S, Cecconello I, Iriya K, Marson AG, Takeda FR, Gama-Rodrigues JJ.
    Clinics (Sao Paulo); 2005 Apr; 60(2):103-12. PubMed ID: 15880245
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Methylene blue chromoendoscopy for the detection of Barrett's esophagus in a Greek cohort.
    Kouklakis GS, Kountouras J, Dokas SM, Molyvas EJ, Vourvoulakis GP, Minopoulos GI.
    Endoscopy; 2003 May; 35(5):383-7. PubMed ID: 12701007
    [Abstract] [Full Text] [Related]

  • 25. [Immunohistochemical expression of the p53 and Ki-67 proteins in Barrett's esophagus in Korea].
    Kim CW, Lee BI, Kim BW, Kim JI, Park SH, Kim JK, Han SW, Jung IS, Sun HS, Lee AW, Lee KY.
    Korean J Gastroenterol; 2005 Sep; 46(3):189-95. PubMed ID: 16179838
    [Abstract] [Full Text] [Related]

  • 26. Expression of CDX2 and MUC2 in Barrett's mucosa.
    Steininger H, Pfofe DA, Müller H, Haag-Sunjic G, Fratianu V.
    Pathol Res Pract; 2005 Sep; 201(8-9):573-7. PubMed ID: 16259110
    [Abstract] [Full Text] [Related]

  • 27. Cytokeratin immunoreactivity patterns in short-segment Barrett's esophagus in Japanese patients.
    Yagi K, Nakamura A, Sekine A.
    J Gastroenterol Hepatol; 2005 Jun; 20(6):929-34. PubMed ID: 15946143
    [Abstract] [Full Text] [Related]

  • 28. Cytokeratin and CDX-2 expression in Barrett's esophagus.
    van Baal JW, Bozikas A, Pronk R, Ten Kate FJ, Milano F, Rygiel AM, Rosmolen WD, Peppelenbosch MP, Bergman JJ, Krishnadath KK.
    Scand J Gastroenterol; 2008 Jun; 43(2):132-40. PubMed ID: 18224560
    [Abstract] [Full Text] [Related]

  • 29. Immunoreactivity of cytokeratins 7 and 20 in goblet cells and columnar blue cells in patients with endoscopic evidence of Barrett's esophagus.
    Cantarelli JC, Fagundes RB, Meurer L, Rocha MP, Nicola A, Kruel CD.
    Arq Gastroenterol; 2009 Jun; 46(2):127-31. PubMed ID: 19578614
    [Abstract] [Full Text] [Related]

  • 30. Expression profile and cellular localizations of mucin proteins, CK7, and cytoplasmic p27 in Barrett's esophagus and esophageal adenocarcinoma.
    Ozcan HEA, Anuk T, Ozden O.
    Adv Med Sci; 2018 Sep; 63(2):296-300. PubMed ID: 29803118
    [Abstract] [Full Text] [Related]

  • 31. Phenotype of Barrett's esophagus and intestinal metaplasia of the distal esophagus and gastroesophageal junction: an immunohistochemical study of cytokeratins 7 and 20, Das-1 and 45 MI.
    Glickman JN, Wang H, Das KM, Goyal RK, Spechler SJ, Antonioli D, Odze RD.
    Am J Surg Pathol; 2001 Jan; 25(1):87-94. PubMed ID: 11145256
    [Abstract] [Full Text] [Related]

  • 32. ErbB2 without erbB3 expression in metaplastic columnar epithelium of Barrett's esophagus.
    Nishigaki H, Wada K, Tatsuguchi A, Sueoka N, Futagami S, Gudis K, Miyake K, Tsukui T, Sakamoto C.
    Digestion; 2004 Jan; 70(2):95-102. PubMed ID: 15375338
    [Abstract] [Full Text] [Related]

  • 33. Non-biopsy detection of intestinal metaplasia and dysplasia in Barrett's esophagus: a prospective multicenter study.
    Sharma P, Marcon N, Wani S, Bansal A, Mathur S, Sampliner R, Lightdale C.
    Endoscopy; 2006 Dec; 38(12):1206-12. PubMed ID: 17163320
    [Abstract] [Full Text] [Related]

  • 34. Barrett's esophagus and cardiac intestinal metaplasia: two conditions within the same spectrum.
    White NM, Gabril M, Ejeckam G, Mathews M, Fardy J, Kamel F, Doré J, Yousef GM.
    Can J Gastroenterol; 2008 Apr; 22(4):369-75. PubMed ID: 18414711
    [Abstract] [Full Text] [Related]

  • 35. [Biopsy methods and pathology of Barrett's esophagus].
    Takubo K, Honma N, Sawabe M, Arai T, Tanaka Y, Kino K, Iwakiri K.
    Nihon Rinsho; 2005 Aug; 63(8):1429-33. PubMed ID: 16101234
    [Abstract] [Full Text] [Related]

  • 36. Adenocarcinoma of the upper esophagus arising in heterotopic gastric mucosa: common pathogenesis with Barrett's adenocarcinoma?
    Chatelain D, de Lajarte-Thirouard AS, Tiret E, Flejou JF.
    Virchows Arch; 2002 Oct; 441(4):406-11. PubMed ID: 12516606
    [Abstract] [Full Text] [Related]

  • 37. Methylene blue selectively stains intestinal metaplasia in Barrett's esophagus.
    Canto MI, Setrakian S, Petras RE, Blades E, Chak A, Sivak MV.
    Gastrointest Endosc; 1996 Jul; 44(1):1-7. PubMed ID: 8836709
    [Abstract] [Full Text] [Related]

  • 38. Cardiac mucosa in the remnant esophagus after esophagectomy is an acquired epithelium with Barrett's-like features.
    Lord RV, Wickramasinghe K, Johansson JJ, Demeester SR, Brabender J, Demeester TR.
    Surgery; 2004 Sep; 136(3):633-40. PubMed ID: 15349112
    [Abstract] [Full Text] [Related]

  • 39. Cytokeratin 7/20 and MUC1, 2, 5AC, and 6 expression patterns in Barrett's esophagus and intestinal metaplasia of the stomach: intestinal metaplasia of the cardia is related to Barrett's esophagus.
    Gulmann C, Shaqaqi OA, Grace A, Leader M, Patchett S, Butler D, Kay E.
    Appl Immunohistochem Mol Morphol; 2004 Jun; 12(2):142-7. PubMed ID: 15354740
    [Abstract] [Full Text] [Related]

  • 40. Immunohistochemical markers for Barrett's esophagus and associations to esophageal Z-line appearance.
    Wallner B, Sylvan A, Janunger KG, Bozoky B, Stenling R.
    Scand J Gastroenterol; 2001 Sep; 36(9):910-5. PubMed ID: 11521979
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.